---
title: "Goldman Sachs Keeps Their Hold Rating on Grupo Cibest (CIB)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292896276.md"
description: "Goldman Sachs maintained a Hold rating on Grupo Cibest (CIB) with an $81.00 price target. The broader analyst consensus for the stock is also a Hold, with an average price target of $72.75."
datetime: "2026-07-16T11:05:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292896276.md)
  - [en](https://longbridge.com/en/news/292896276.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292896276.md)
generator: "portal-rs"
---

# Goldman Sachs Keeps Their Hold Rating on Grupo Cibest (CIB)

Goldman Sachs analyst maintained a Hold rating on Grupo Cibest today and set a price target of $81.00.

### TipRanks Welcomes a New ETF – NYSE:RANK

-   TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
-   RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.

Currently, the analyst consensus on Grupo Cibest is a Hold with an average price target of $72.75.

### Related Stocks

- [CIB.US](https://longbridge.com/en/quote/CIB.US.md)
- [GS.US](https://longbridge.com/en/quote/GS.US.md)
- [RANK.US](https://longbridge.com/en/quote/RANK.US.md)
- [W4VR.SG](https://longbridge.com/en/quote/W4VR.SG.md)

## Related News & Research

- [Grupo Cibest S.A. - Sponsored ADR Declares Special Dividend of $1.63 (NYSE:CIB)](https://longbridge.com/en/news/297359379.md)
- [Grupo Cibest S.A. - Sponsored ADR (NYSE:CIB) Receives Average Recommendation of "Hold" from Analysts](https://longbridge.com/en/news/294363597.md)
- [REG - Mirae Asset ETF ICAV - Global X ETF ICAV 01.09.26](https://longbridge.com/en/news/297758261.md)
- [Goldman Sachs lifts Hugo Boss voting rights to 17.63% from 16.96%](https://longbridge.com/en/news/297505658.md)
- [Canadians Can Now Trade on TipRanks](https://longbridge.com/en/news/297425716.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**